Nasdaq 100 Stocks SEC Filings — April 30, 2026

30-04-2026

Intellia Therapeutics entered into an underwriting agreement on April 28, 2026, for a public offering of 16,744,187 shares of common stock at $10.75 per share, with underwriters exercising the full 30-day option for an additional 2,511,628 shares, yielding net proceeds of approximately $194.6 million after discounts and expenses. As of March 31, 2026, the company's preliminary unaudited cash, cash equivalents, and marketable securities stood at $517.2 million, bolstered by $33.6 million in net proceeds from an at-the-market equity offering program during the quarter. The net proceeds will fund clinical development, pipeline advancement, potential acquisitions, and general corporate purposes, extending the cash runway into at least 2028.

• ·Offering closed on April 30, 2026; underwriter option exercised in full on April 29, 2026
• ·Potential approval of lonvoguran ziclumeran for hereditary angioedema anticipated in first half of 2027
• ·Underwriting agreement includes customary representations, warranties, covenants, and indemnification
• ·Preliminary financial data not audited or reviewed by Deloitte & Touche LLP

30-04-2026

Tesla's 10-K/A filing details Elon Musk's compensation history, noting he has not accepted his minimum wage base salary since May 2019 and outlining the 2025 CEO Performance Award Agreement with 12 operational milestones including 20 million vehicles delivered, 10 million FSD subscriptions, 1 million bots and Robotaxis, and escalating Adjusted EBITDA targets up to $400 billion across three non-overlapping four-quarter periods. The 2025 CEO Interim Award of 96 million restricted shares, purchased at $23.34 per share and issued August 15, 2025, was fully forfeited in April 2026. Musk's beneficial ownership includes 413,152,109 shares held by his trust and 303,960,630 exercisable options as of December 31, 2025, with 207,498,721 shares eligible to be pledged.

• ·Adjusted EBITDA defined as net income attributable to common stockholders before interest expense, provision for income taxes, depreciation, amortization and impairment, stock-based compensation, and digital assets gains/losses over four consecutive fiscal quarters.
• ·2025 CEO Interim Award approved by Board on August 3, 2025; scheduled to vest on second anniversary subject to continuous service.
• ·2018 CEO Performance Award vesting: 1/12th per tranche upon market cap increases ($100B initial + $50B increments) and one of 16 operational milestones.
• ·Total CEO realized compensation includes salary, bonus, non-equity incentives, other comp, plus gains from exercised options and vested restricted stock (net of tax sales).

30-04-2026

First Northern Community Bancorp reported first quarter 2026 net income of $5.9 million ($0.36 per diluted share), up 60.9% YoY from $3.7 million ($0.22 per diluted share), fueled by net interest income growth of 7.91% to $17.2 million, non-interest income up 19.75% to $1.7 million, and non-interest expense down 4.81% to $11.0 million. Total assets reached $1.92 billion (up 2.6% YoY), net loans $1.06 billion (up 2.3% YoY, driven by commercial but offset by declines in CRE, agriculture, residential, and consumer), and deposits $1.69 billion (up 1.2% YoY); however, QoQ net income declined 1.2% to $5.9 million from $6.0 million, net interest income fell 3.0%, and cash equivalents dropped 4.1%. The company issued a 5% stock dividend, announced a repurchase of up to 6% of shares, and uplisted to Nasdaq Capital Market post-quarter.

• ·ROAA 1.24% (up YoY from 0.79%, flat QoQ from 1.23%)
• ·ROAE 11.21% (down QoQ from 11.40%, up YoY from 8.23%)
• ·Total risk-based capital ratio exceeds 10%, with Total capital ratio 19.1%
• ·Book value per share $13.03 (up from $12.92 at Dec 31 2025 and $11.25 at Mar 31 2025)
• ·Provision for credit losses $300k (vs $850k YoY and reversal of $850k QoQ)
• ·Cost of funds 0.90% (up slightly YoY from 0.86%)

30-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 30, 2026, announcing the issuance of a press release titled 'AITX's RAD Enters Hospitality Sector with First Major Hotel Brand Order.' This represents the company's expansion into the hospitality sector via its RAD product with its inaugural major order from a hotel brand. No financial details or performance metrics were disclosed.

30-04-2026

ImmunityBio, Inc. (IBRX) filed DEFA14A additional proxy materials for its 2026 Annual Meeting on June 9, 2026, at 10:30 A.M. PT virtually, proposing the election of nine director nominees and ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026. The board recommends voting 'FOR' all proposals, with proxy materials available online and voting deadline of June 8, 2026, 11:59 PM ET.

• ·Request paper/email copies of materials by May 26, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com.
• ·Virtual meeting access: www.virtualshareholdermeeting.com/IBRX2026.

30-04-2026

Vanguard Capital Management LLC filed a Schedule 13G on April 30, 2026, disclosing beneficial ownership of 316347733 shares of Netflix Inc common stock, representing 7.49% of the outstanding shares as of March 31, 2026. The ownership is held passively under Rule 13d-1(b) by Vanguard and its affiliates, including investment companies and managed accounts, with no intent to change or influence control of Netflix Inc.

• ·Filing confirms securities held in ordinary course of business by investment companies under Investment Company Act of 1940 and other managed accounts.
• ·No single other person's interest exceeds 5%.

30-04-2026

Amazon reported strong Q1 2026 results with total net sales increasing 16.6% YoY to $181,519M, driven by 11.5% growth in net product sales to $71,304M and 20.2% in net service sales to $110,215M; net income surged 76.7% YoY to $30,255M with diluted EPS at $2.78. Operating cash flow rose 53% YoY to $26,032M, though investing cash flow deteriorated to -$64,212M due to sharply higher capex of $44,203M (up 76.7% YoY). Total assets grew to $916,630M, but inventories declined slightly to $36,534M.

• ·Long-term debt increased to $119,074M from $65,648M as of Dec 31 2025.
• ·TTM net cash from operating activities reached $148,531M, up from $113,903M.
• ·Diluted shares used: 10,874M in Q1 2026 vs 10,793M in Q1 2025.

30-04-2026

Acadia Healthcare reported Q1 2026 revenue of $828,802 thousand, up 7.6% YoY from $770,505 thousand, driven by 14.2% growth in acute inpatient psychiatric facilities to $470,653 thousand and 6.3% in residential treatment centers, while specialty treatment facilities declined 6.5% to $128,116 thousand and comprehensive treatment centers grew modestly 2.5% YoY. However, net income attributable to ACHC fell 51% to $4,105 thousand from $8,374 thousand, with EPS dropping to $0.05 from $0.09, due to higher legal settlements expense ($13,751 thousand vs $3,504 thousand), professional fees, and interest expense. Operating cash flow improved sharply to $61,531 thousand from $11,477 thousand.

• ·Medicaid revenue increased to 60.7% of total ($503,406 thousand) from 55.9% ($430,814 thousand), while commercial payer mix declined to 22.4% ($185,926 thousand) from 25.0%.
• ·Accounts receivable, net increased QoQ to $471,752 thousand from $440,604 thousand as of December 31, 2025.
• ·Capital expenditures were $76,564 thousand in Q1 2026, down significantly from $174,631 thousand in Q1 2025.

30-04-2026

Canadian Pacific Kansas City Ltd (CP) reported Q1 2026 total revenues of $3,701 million, down 2% YoY from $3,795 million, with freight revenues declining 3% to $3,628 million as most segments decreased (e.g., Forest products -17%, Coal -12%) while Grain grew 11% to $871 million. Operating income fell 4% to $1,258 million and net income dropped 7% to $845 million (EPS $0.94 vs $0.98), though cash from operations was $976 million and the company ramped up share repurchases to $680 million from $347 million. Comprehensive income rose sharply to $1,398 million from $881 million, boosted by a $538 million foreign currency translation gain.

• ·Weighted-average basic shares decreased to 896.8 million from 933.2 million YoY due to repurchases.
• ·Dividends declared per share increased to $0.228 from $0.190.
• ·Additions to properties decreased to $664 million from $711 million.
• ·Long-term debt increased to $21,883 million as at March 31, 2026 from $19,948 million at Dec 31, 2025.

30-04-2026

Alphabet Inc. reported Q1 2026 revenues of $109,896M, up 21.8% YoY from $90,234M, with net income surging 81.1% YoY to $62,578M driven by strong Google Cloud growth of 63.4% to $20,028M and Google advertising up 15.5% to $77,253M. However, Google Network revenues declined 3.9% YoY to $6,971M, Other Bets fell 8.7% to $411M, and the company recorded hedging losses of $180M versus gains of $260M prior year. Total assets expanded to $703,919M, bolstered by acquisitions totaling $33,621M net.

• ·Operating cash flow increased 26.7% YoY to $45,790M.
• ·No stock repurchases in Q1 2026 versus $15,068M in Q1 2025.
• ·Long-term debt rose to $77,501M from $46,547M as of Dec 31, 2025.
• ·Goodwill increased to $57,774M from $33,380M, reflecting acquisitions.
• ·Dividends declared at $0.21 per share, up from $0.20 prior year.
• ·Net cash used in investing activities widened to $63,389M from $16,194M.

30-04-2026

Meta Platforms reported Q1 2026 revenue of $56,311M, up 33.1% YoY from $42,314M, with net income surging 60.8% YoY to $26,773M driven by strong operating income growth of 30.3% to $22,872M. However, cash and equivalents declined 34.7% QoQ to $23,426M amid elevated capex of $18,997M (up 46.7% YoY) and R&D expenses rising 45.7% YoY to $17,699M, while interest and other expense turned negative at ($1,120M). Operating cash flow increased 34.1% YoY to $32,226M, supporting total assets growth of 8.0% QoQ to $395,250M.

• ·Dividends and dividend equivalents declared at $0.525 per share, totaling $1,370M in Q1 2026.
• ·Earnings per basic share: $10.57 (Q1 2026) vs. $6.59 (Q1 2025).
• ·Net cash used in investing activities: $33,678M in Q1 2026, up from $20,010M YoY.
• ·Share-based compensation expense: $6,032M in Q1 2026, up from $4,147M YoY.

30-04-2026

Munich Reinsurance Co Stock Corp in Munich filed a 13F-HR report disclosing 175 U.S. equity holdings totaling $4,068,207,385 as of March 31, 2026. Top positions include NVIDIA Corp. ($200,921,357), Microsoft Corp. ($175,594,582), Alphabet Inc. Class C ($101,931,111), Alphabet Inc. Class A ($91,843,788), and Merck & Co. ($90,534,705). All reported holdings are held with sole voting and dispositive power, reflecting a diversified portfolio across technology, healthcare, financials, and other sectors.

• ·Filing date: April 30, 2026
• ·Report period end: March 31, 2026
• ·All positions reported with sole voting power, shared voting power, sole dispositive power, and shared dispositive power of zero
• ·Business address: Koeniginstr. 107, Munich, Germany 80802

30-04-2026

Smurfit Westrock reported Q1 2026 Net Sales of $7,712 million, up 0.7% YoY from $7,656 million, but Net Income declined sharply 83.5% to $63 million (0.8% margin) from $382 million (5.0% margin), impacted by $65 million in adverse weather costs primarily in North America. Adjusted EBITDA fell 14.1% to $1,076 million (14.0% margin) from $1,252 million (16.4% margin), while Net Cash Provided by Operating Activities decreased to $204 million from $235 million. The company announced a quarterly dividend of $0.4523 per share, reaffirmed FY2026 Adjusted EBITDA guidance of $5.0-5.3 billion, and noted a review of its LSE listing that may lead to delisting.

• ·Containerboard pricing increased net $20 per ton in Q1 2026, with further $30 per ton increases in April.
• ·Review of LSE listing underway, may result in delisting (NYSE primary listing unaffected); update expected May 2026.
• ·Latin American business delivered ~20% Adjusted EBITDA margin.
• ·Entered consultations for UK mill (200k tonnes containerboard) and four converting facilities in UK/Netherlands.
• ·Quarterly dividend payable June 10, 2026 to shareholders of record May 15, 2026.

30-04-2026

CCC Intelligent Solutions Holdings Inc. reported Q1 2026 revenue of $281.3 million, up 12% YoY from $251.6 million, with adjusted EBITDA increasing 21% to $120.2 million and margin expansion of approximately 300 basis points to 43%. GAAP operating income swung to $48.8 million from a $10.7 million loss, and adjusted operating income rose to $106.8 million. However, cash from operations slightly declined to $57.5 million from $58.5 million, free cash flow fell to $41.6 million from $43.6 million, and cash balances dropped to $36.9 million amid $400 million in share repurchases.

• ·Q2 2026 guidance: Revenue $283.0M to $285.0M; Adjusted EBITDA $111.0M to $113.0M.
• ·FY 2026 guidance: Revenue $1.155B to $1.163B; Adjusted EBITDA $484.0M to $490.0M.
• ·Added John Schweitzer to Board of Directors.
• ·Expanded relationship with top-five insurer (by 2024 direct premiums) via multi-year agreement for APD and AI solutions.
• ·Signed multi-year Casualty platform agreement with another top-five insurer; prior top-six insurer decision in Q4 2025.
• ·$100M remaining under $500M share repurchase authorization.
• ·Cash and cash equivalents decreased to $36.9M from $111.2M at Dec 31, 2025.

30-04-2026

Acadian Asset Management Inc. reported record Q1'26 net inflows of $21.4B (12% of beginning AUM), driving AUM to a record $195.7B, up 61% YoY from $121.9B, with management fees reaching $159.3M, up 41% YoY. ENI surged 85% YoY to $37.6M with EPS up 94% to $1.05, and operating margin expanded 978 bps to 38.1%; however, U.S. GAAP operating margin contracted 152 bps to 25.1% and 1-year benchmark outperformance fell to 67% of revenue-weighted assets from 85% a year ago.

• ·Dividend of $0.10 per share payable June 26, 2026 to shareholders of record June 12, 2026.
• ·96% of strategies by revenue beat benchmarks over 3-, 5-, and 10-year periods as of March 31, 2026.
• ·Leverage ratio 1.3x and net leverage 0.7x as of March 31, 2026.
• ·Conference call held April 30, 2026 at 11:00 a.m. ET.

30-04-2026

Groupe des Assurances du Credit Mutuel filed a 13F-HR report on April 30, 2026, disclosing its equity holdings as of March 31, 2026, with a total portfolio value of $202,384,441 across five positions. Key holdings include Stellantis N.V. at $71,281,577 (10,053,819 shares), Ferrari NV at $62,613,250 (185,000 shares), and Microsoft Corp at $34,647,912 (93,600 shares). No changes in holdings or voting authority were reported (all defined with sole discretion).

• ·Filing CIK: 0002056266
• ·SEC File Number: 028-25255
• ·Report period end: March 31, 2026
• ·All holdings reported as SH DFND (shares, defined, sole voting authority)

30-04-2026

NorthEast Community Bancorp reported net income of $10.0 million for the three months ended March 31, 2026, down 5.7% from $10.6 million in the prior year period, with net interest income declining 0.5% YoY to $24.1 million and net interest margin contracting 2.4% to 4.99%. Total assets decreased 1.9% QoQ to $2.0 billion, and net loans fell 1.7% QoQ to $1.8 billion, though deposits edged up 0.6% QoQ to $1.6 billion. Positively, asset quality remained flawless with no non-performing loans, construction loan commitments rose 37.8% YoY with $819 million in unfunded commitments (up 20.6% QoQ), and performance metrics included ROA of 1.97% and ROE of 11.13%.

• ·Loan originations totaled $266.1 million in Q1 2026, primarily $244.2 million in construction loans.
• ·No credit loss expense recorded in Q1 2026 vs. $237,000 in Q1 2025.
• ·Charge-offs of $27,000 in Q1 2026 vs. $117,000 in Q1 2025.
• ·NOW/money market accounts increased 16.5% QoQ, offsetting declines in certificates of deposit down 6.3% QoQ.
• ·Borrowings decreased 71.4% QoQ to $20.0 million.

30-04-2026

Optimum Communications, Inc. (OPTU) filed a DEFA14A Definitive Additional Proxy Materials on April 30, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was submitted by the registrant with no fee required and is categorized as Definitive Additional Materials. No specific proposals, financial data, or substantive details are included in the provided filing excerpt.

30-04-2026

Vanguard Capital Management LLC filed Schedule 13G disclosing beneficial ownership of 64,386,654 shares of PayPal Holdings, Inc. common stock, representing 6.99% of the outstanding shares as of March 31, 2026. The filing is under Rule 13d-1(b) and certifies passive investment held in the ordinary course of business with no intent to influence control.

• ·Filed on April 30, 2026, reflecting ownership as of March 31, 2026
• ·No single other person's interest in the reported securities exceeds 5%
• ·Securities held by Vanguard funds and managed accounts over which Vanguard exercises dispositive power

30-04-2026

Vanguard Capital Management LLC and affiliates filed Schedule 13G disclosing beneficial ownership of 555988240 shares of Microsoft Corp common stock, representing 7.48% as of March 31, 2026. The filer reports no sole voting or dispositive power, with all power shared (555988240 shares for both voting and dispositive). This is a passive investment filing under Rule 13d-1(b) with certification of no intent to influence control.

• ·Filing date: April 30, 2026
• ·CUSIP: 594918104
• ·Passive investor (IA) under SEC Release No. 34-39538

30-04-2026

Isthmus Partners, LLC filed a 13F-HR on April 30, 2026, reporting 218 equity holdings with a total market value of $953,359,795 as of March 31, 2026. The portfolio features significant positions in ETFs and blue-chip stocks, including iShares Core MSCI EAFE ETF at $46,245,259, Apple Inc. at $23,078,800, and Alphabet Inc. Class A at $20,178,660. The firm exercises sole voting authority on the majority of shares across its diversified holdings.

• ·Report period end date: 20260331
• ·Filed as of date: 20260430
• ·Central Index Key: 0001639666
• ·SEC file number: 028-16855
• ·Business address: One South Pinckney Street, Suite 818, Madison, WI 53703

30-04-2026

Camden Property Trust entered into new 'at the market' sales agreements on April 28, 2026, with managers including Deutsche Bank Securities Inc., BMO Capital Markets Corp., Regions Securities LLC, Scotia Capital (USA) Inc., and Truist Securities, Inc., for the offer and sale of up to $500,000,000 in common shares, renewing the program expiring May 12, 2026. The agreements allow sales of primary shares and forward hedge shares, with no obligation to sell any shares. Net proceeds, if any, will be used for general corporate purposes including reducing borrowings under its $1.2 billion unsecured revolving credit facility.

• ·Existing ATM agreements terminated on April 28, 2026.
• ·Sales of shares to be made via ordinary brokers’ transactions at market or negotiated prices.
• ·Forward sale agreements may be physically, cash, or net share settled.
• ·Registration statement on Form S-3 and prospectus supplement filed April 28, 2026.
• ·Agreements filed as Exhibits 1.1 through 1.5.

30-04-2026

Costello Asset Management, INC filed its 13F-HR on April 30, 2026, disclosing equity holdings as of March 31, 2026, with a total portfolio market value of $289,231,312 across 685 positions, all held with sole voting authority. Top holdings include Amazon.com Inc ($23,399,843), Apple Inc ($22,939,208), Alphabet Inc Class A ($17,012,718), Alphabet Inc Class C ($13,480,997), and Chubb Ltd ($4,083,251). The portfolio shows broad diversification across sectors including technology, healthcare, and consumer goods.

• ·All 685 positions held with sole investment discretion.
• ·Filing CIK: 0001760145; SEC file number: 028-19075.
• ·No shared voting authority or other managers reported.

30-04-2026

Zoom Communications, Inc. (ZM) filed a DEFA14A (Definitive Additional Materials) proxy statement on April 30, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is by the registrant with no fee required and supplements ongoing proxy solicitation efforts. No specific proposals, financial data, or shareholder actions are detailed in the provided filing header.

30-04-2026

The Special Meeting of Shareholders of abrdn National Municipal Income Fund (VFL) was adjourned from March 11, 2026, to May 6, 2026, to secure additional votes for the proposed Agreement and Plan of Reorganization with MFS Municipal Income Trust. An overwhelming majority of shares that have voted are in favor, but the proposal requires approval by more than 50% of outstanding shares to pass. The Board recommends voting FOR, citing benefits including increased fund size, broader investment mandate, lower expense ratio, and enhanced efficiencies.

• ·Filing Date: April 30, 2026
• ·Proxy materials available at https://www.sec.gov/ and https://vote.proxyonline.com/aberdeen/docs/VFL.pdf
• ·Voting methods: phone with representative (800-290-6427), touch-tone phone, online, or mail

30-04-2026

For Q1 2026, NCS Multistage Holdings, Inc. reported total revenues of $45,637, down 8.8% YoY from $50,005, with both product sales (-7.1% to $32,583) and services (-12.7% to $13,054) declining. Income from operations fell sharply 80.2% YoY to $848, resulting in a net loss attributable to the company of $371 versus $4,056 profit in Q1 2025; however, cash from operating activities improved to $1,280 from $(1,645). Total assets decreased QoQ to $174,583 from $181,199 as of December 31, 2025.

• ·Paid contingent purchase consideration of $1,250 in Q1 2026.
• ·Non-controlling interest net income $2,112 in Q1 2026 vs $398 in Q1 2025.
• ·Net cash used in investing activities $(559) in Q1 2026.

30-04-2026

Weave Communications reported first quarter 2026 total revenue of $65.5 million, up 17.4% year-over-year from $55.8 million, with GAAP gross margin expanding 100 basis points to 72.6% and Non-GAAP income from operations reaching $2.5 million versus breakeven in the prior year. GAAP net loss narrowed to $5.8 million ($0.07 per share) from $8.8 million ($0.12 per share), though losses persisted on a GAAP basis. The company guided for Q2 2026 revenue of $67.2-68.2 million and full-year revenue of $275.0-278.0 million, with Non-GAAP income from operations of $2.1-3.1 million in Q2 and $10.5-13.5 million for the full year.

• ·Named to G2’s 2026 Best Software Awards, #2 on Best Healthcare Software Products list.
• ·Selected as exclusive ADA-endorsed patient engagement platform for 152,000 members.
• ·Over 50% of customer locations using AI tools embedded in the platform.
• ·Most customer location additions in a single quarter in company history.

30-04-2026

Dyadic International Inc. (DYAI) filed a 10-K/A amendment on April 30, 2026, primarily updating Item 15 with an extensive list of exhibits comprising material contracts, leases, licenses, and agreements spanning from 2015 to 2026. Notable recent additions include a Grant Agreement with the Bill & Melinda Gates Foundation dated November 16, 2024, a License and Development Agreement with Proliant Biologicals, LLC dated June 27, 2024, and an At-The-Market Issuance Sales Agreement with Craig-Hallum Capital Group LLC dated March 6, 2026. The filing references prior disclosures via 8-K, 10-Q, and other forms without introducing new financial data or performance metrics.

• ·Alphazyme Sale Agreement dated January 18, 2023, previously filed in 8-K on January 23, 2023
• ·RUBIC License Agreement dated April 6, 2023, previously filed in 8-K on April 6, 2023
• ·Inzyme Development and Exclusive License Agreement effective September 18, 2023, previously filed in 8-K on September 19, 2023
• ·Securities Purchase Agreement, Registration Rights Agreement, Security Agreement, and Subsidiary Guarantee all dated March 8, 2024, previously filed in 8-K on March 11, 2024
• ·Amendment to Security Agreement dated September 15, 2025, previously filed in 8-K on September 16, 2025

30-04-2026

Cumulus Media Inc's 2025 STIP achieved a total weighted payout of 82.8%, with strong outperformance in Adjusted Controllable Expenses at 150% payout ($422.6M actual vs. $424.4M max) and Digital Marketing Services Revenue at 104.3% payout ($63.2M actual vs. $62.6M target). However, Adjusted EBITDA underperformed at 53.2% payout ($57.8M actual vs. $70M target), and 2025 PRSU goals were set at $63.0M threshold and $70M target for Adjusted EBITDA.

• ·70% of overall award split into three tranches for 2025-2027 performance period, each eligible to vest 0-150% based on Adjusted EBITDA Margin (ex-political).
• ·2025 Adjusted EBITDA Margin goals: Threshold flat to prior year (50% payout), Target 75 bps improvement (100% payout), Maximum 175 bps improvement (150% payout).

30-04-2026

Arcadia Biosciences, Inc. (RKDA) filed a 10-K/A on April 30, 2026, detailing outstanding stock options for directors with exercise prices ranging from $2.71 to $1,376 per share, the majority deeply underwater relative to recent grants at $2.71-$4.80. Executive compensation declined significantly in 2025 versus 2024, with CEO Thomas J. Schaefer's total pay dropping 40% to $300,001 (no bonus) and former CFO Mark Kawakami's falling 41% to $218,425. Insiders and directors as a group beneficially own 4.5% of shares, while two 5% stockholders each hold 9.9%.

• ·Equity compensation plans: 179,963 shares issuable upon exercise (approved, weighted avg price $14.65); 51,876 (unapproved, weighted avg $1.34); total weighted avg $11.67.
• ·No shares remaining available for future issuance under equity compensation plans.
• ·Director fees: Albert D. Bolles $46,000; Deborah Carosella $56,500; Gregory Waller $64,000; Lilian Shackelford Murray $65,500; Amy Yoder $62,000.

30-04-2026

CoStar Group, Inc. (CSGP) filed Definitive Additional Materials (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled virtually on June 23, 2026 at 10:00 a.m. EDT. Shareholders are to vote on electing eight director nominees (Louise S. Sams, Andrew C. Florance, John L. Berisford, Angelique G. Brunner, Rachel C. Glaser, John W. Hill, Christine M. McCarthy, Robert W. Musslewhite), ratifying Ernst & Young LLP as the independent auditor for 2026, advisory approval of executive compensation, and approval of the 2026 Employee Stock Purchase Plan, with the Board recommending 'For' all proposals.

• ·Voting deadline: June 22, 2026 11:59 P.M. EDT
• ·Proxy materials request deadline: June 9, 2026
• ·Virtual meeting URL: www.virtualshareholdermeeting.com/CSGP2026
• ·Vote online at www.ProxyVote.com or by phone/mail after requesting paper copy

30-04-2026

Aqua Metals, Inc. disclosed pay versus performance data in its 10-K/A, with CEO summary compensation rising 28% YoY to $1,869,000 in 2025 from $1,460,000 in 2024, and average non-CEO NEO summary compensation increasing slightly 2% to $736,313. However, CEO compensation actually paid plunged 93% to $62,198, and average non-CEO NEO actual pay declined 57% to $314,630, aligning with Total Shareholder Return dropping 81% to $1.92 from $10.08. Net losses narrowed 7.8% YoY to $(22,646,000) from $(24,555,000), but remained substantial following $(23,938,000) in 2023.

• ·TSR declined 83% from $60.80 in 2023 to $10.08 in 2024
• ·CEO Grant Date Fair Value of Equity Awards 2025: $(729,051)
• ·Net loss widened 2.6% from $(23,938,000) in 2023 to $(24,555,000) in 2024

30-04-2026

Apple reported record Q2 FY2026 revenue of $111.2 billion, up 17% YoY to $111,184 million, driven by iPhone revenue record of $56,994 million (up 22% YoY) and Services all-time high of $30,976 million (up 16% YoY), with double-digit growth across all geographic segments. However, Mac revenue grew modestly 6% YoY to $8,399 million, iPad 8% to $6,914 million, and Wearables, Home and Accessories 5% to $7,901 million. Diluted EPS reached $2.01, up 22% YoY, with over $28 billion in quarterly operating cash flow, a 4% dividend increase to $0.27 per share, and authorization of an additional $100 billion stock repurchase.

• ·Dividend payable May 14, 2026 to shareholders of record May 11, 2026.
• ·Q2 FY2026 net income $29,578 million, up 19% YoY.
• ·Total assets increased to $371,082 million from $359,241 million as of September 27, 2025.
• ·Six months FY2026 net sales $254,940 million, up 16% YoY.
• ·Earnings conference call live stream at 2:00 p.m. PT on April 30, 2026 at apple.com/investor/earnings-call.

30-04-2026

Genco Shipping & Trading Limited filed a 10-K/A amendment detailing executive compensation practices, governance, and select financial highlights. For Q4 2025, the company achieved net income of $15.4 million and Adjusted EBITDA of $42.0 million, marking the highest quarterly Adjusted EBITDA since Q4 2022. Dividends were declared for 26 consecutive quarters, totaling $7.565 per share, equivalent to approximately 40% of the share price as of December 31, 2025.

• ·Compensation metrics for bonuses: Adjusted EBITDA threshold $50M (25% payout), target $90-95M (100% payout), stretch $160M (200% payout) with 60% weighting; Strategic Initiatives 40% weighting.
• ·Equity plan features: three-year minimum vesting for NEOs, double-trigger change in control vesting, fixed shares subject to shareholder approval.
• ·Prohibitions: no short sales/hedging/pledging of equity (one grandfathered exception), no tax gross-ups, no significant perqs, no pre-vesting dividends, no guaranteed increases, no repricing of underwater options.

30-04-2026

Reading International Inc (RDIB) filed a 10-K/A amendment on April 30, 2026, disclosing equity compensation plan details showing 1,915,069 stock options outstanding with a weighted average exercise price of $1.64 and 870,833 securities remaining available for future issuance under restricted stock units. The filing primarily incorporates numerous exhibits by reference from prior 10-K, 10-Q, and 10-K/A reports, including loan modifications, indemnification agreements, insider trading policies, certifications, and consents. No period-over-period financial comparisons or performance metrics are provided.

• ·Equity compensation plans approved by security holders.
• ·Exhibits include consents, SOX 302/906 certifications, list of subsidiaries, and iXBRL financial statements from 10-K for year ended December 31, 2025.

30-04-2026

Ducommun Incorporated held its 2026 Annual Meeting of Shareholders on April 29, 2026, where shareholders elected Stephen G. Oswald and Samara A. Strycker as Class I directors for three-year terms expiring in 2029, approved executive compensation on an advisory basis, ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved an amendment and restatement of the 2024 Stock Incentive Plan. All four proposals passed with strong majorities, as For votes significantly outnumbered Against, Withheld, Abstain, and Broker Non-Votes across the board. No proposals faced significant opposition.

• ·Shareholder meeting held on April 29, 2026; filing dated April 30, 2026
• ·Directors elected for terms expiring at 2029 Annual Meeting
• ·Broker Non-Votes: 917,526 for proposals with such category

30-04-2026

Intellinetics, Inc. (INLX) filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on June 25, 2026, at its Columbus, Ohio headquarters, with a record date of April 28, 2026. Key proposals include electing five directors for one-year terms, approving amendments to increase authorized shares under the 2024 Equity Incentive Plan from 243,122 to 917,157 and under the 2023 Non-Employee Director Compensation Plan from 150,000 to 302,863, advisory votes on named executive officer compensation and vote frequency, and ratifying GBQ Partners LLC as auditors for FY 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Annual Meeting date and time: June 25, 2026, at 3:00 p.m. local time, 2190 Dividend Drive, Columbus, Ohio 43228
• ·Record date: close of business on April 28, 2026
• ·Notice of Internet Availability mailed on or about May 15, 2026
• ·Proxy materials available at https://web.viewproxy.com/inlx/2026

30-04-2026

Intel Corporation issued $6.5 billion in aggregate principal amount of senior notes on April 30, 2026, consisting of $1B 4.650% notes due 2031, $1B 5.000% notes due 2033, $2.25B 5.300% notes due 2036, $1.75B 6.125% notes due 2056, and $0.5B 6.200% notes due 2066. Net proceeds were approximately $6.47 billion after underwriting discounts. The notes were issued pursuant to an underwriting agreement dated April 27, 2026, with Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Barclays Capital Inc., BofA Securities, Inc., and Deutsche Bank Securities Inc. as representatives.

• ·Underwriting agreement dated April 27, 2026.
• ·Notes issued under indenture dated March 29, 2006, as supplemented.
• ·Registration statement on Form S-3 filed January 23, 2026 (File No. 333-292925).

30-04-2026

Immunic, Inc. filed an S-3/A amendment on April 30, 2026, to register shares related to its February 2026 private placement, which raised approximately $200 million in gross proceeds from pre-funded and common warrants. The company completed enrollment in its Phase 3 ENSURE trials (1,121 patients in ENSURE-1 and 1,100 in ENSURE-2) for vidofludimus calcium (IMU-838) in relapsing multiple sclerosis, with topline data expected by end of 2026, following positive Phase 2 CALLIPER results announced in 2025. A 1-for-10 reverse stock split became effective on April 27, 2026, and the company employs 92 people as of February 1, 2026.

• ·Pre-Funded Warrants exercisable at $0.001 per share; Common Warrants at $8.73220 per share.
• ·Reverse Stock Split approved at special meeting on April 14, 2026, effective April 27, 2026.
• ·Headquartered in New York City with main operations in Gräfelfing, Germany.